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KAJIAN KE ATAS PERANAN INPUT ASID AMINO PERANGSANG PADA 
NEURON ROSTRAL VENTROLATERAL MEDULA DAN PENILAIAN 
TINDAK BALAS VASKULAR PERIFERAL DALAM HIPERTENSI 
TERARUH OBESITI 
ABSTRAK 
Rostral ventrolateral medula (RVLM) memainkan peranan penting dalam 
pengawalan tonik dan berfasa tekanan darah. Kajian ini dijalankan bagi menentukan 
sama ada input asid amino perangsang (EAA) ke RVLM menyumbang kepada 
tekanan darah yang tinggi dan untuk menilai tindak balas vaskular periferal dalam 
hipertensi teraruh obesiti. Tikus jantan Sprague-Dawley diberi makan diet rendah-
lemak atau diet sederhana tinggi-lemak (MHF) selama 16 minggu. Kemudian, tikus 
yang diberi makan diet MHF dibahagikan kepada tikus cenderung obes (OP) dan 
tikus rintang obes (OR) berdasarkan taburan berat badan. Tikus OR didefinisikan 
sebagai tikus dengan berat badan yang sama atau kurang dari tikus kawalan (LF) 
manakala tikus OP didefinisikan sebagai tikus dengan berat badan yang paling besar. 
Pada minggu ke-16, tikus digunakan untuk mengkaji peranan EAA ke atas neuron 
RVLM atau untuk mengkaji tindak balas vaskular periferal dalam tikus hipertensi 
teraruh obesiti. Dalam kajian yang pertama, L-glutamat (1 nmol) dan asid kainurenik 
(KYN) pada kepekatan 4 nM, 40 nM dan 4 µM disuntik ke dalam RVLM dan 
heksametonium (20 mg/kg) diberi secara intravena. Batang otak dikeluarkan untuk 
pengesahan histologi dan indeks adipositi dikira. Tikus OP menunjukkan perolehan 
berat badan yang lebih ketara, indeks adipositi yang lebih tinggi dan peningkatan 
tekanan darah. Tindakbalas presor terhadap L-glutamat adalah lebih besar dalam 
tikus OP berbanding tikus OR dan LF, dan keputusan ini mencadangkan peningkatan 
xv 
 
tindak balas RVLM terhadap EAA dan peningkatan peranan input EAA kepada 
neuron vasomotor RVLM. Suntikan KYN pada 40 nM menurunkan tekanan darah 
arteri purata (MAP) dalam tikus OP sahaja manakala pada 4 nM, tiada sebarang 
perubahan yang signifikan pada MAP diperhatikan pada semua tikus. Suntikan KYN 
pada kepekatan 4 µM meningkatkan MAP dalam semua kumpulan tikus. Keputusan 
yang diperolehi mencadangkan terdapat ketidakseimbangan input EAA kepada 
RVLM dalam tikus yang obes, di mana, keseimbangan disesarkan ke arah 
perangsang yang menjurus kepada peningkatan tekanan darah. Yang kedua, 
pertambahan perencatan kepada laluan glutamat perangsang oleh KYN 
berkemungkinan mendedahkan laluan perangsang yang lain yang memerlukan 
penyelidikan lanjutan. Heksametonium menghasilkan penurunan MAP yang lebih 
besar dalam tikus OP berbanding tikus OR dan LF dan keputusan ini mencadangkan 
peningkatan tonik simpatetik vasomotor dalam tikus OP. Untuk kajian tindak balas 
vaskular periferal, pelbagai dos intravena noradrenalina (0.15-5 µg/kg), fenilefrina 
(1-32 µg/kg) dan angiotensin II (3.75-120 ng/kg) menghasilkan tindak balas presor 
bergantungan dos yang lebih besar pada MAP dalam tikus OP yang ternyahsaraf 
berbanding tikus OR dan LF yang ternyahsaraf. Keputusan ini menggambarkan 
peningkatan dalam tindak balas vaskular periferal terhadap agen-agen vasoaktif yang 
mungkin telah menyumbang sebahagiannya kepada tekanan darah yang tinggi dalam 
tikus hipertensi teraruh obesiti. 
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STUDY ON ROLE OF EXCITATORY AMINO ACID INPUT ON ROSTRAL 
VENTROLATERAL MEDULLA NEURONS AND ASSESSMENT OF 
PERIPHERAL VASCULAR REACTIVITY IN OBESITY-INDUCED 
HYPERTENSION 
ABSTRACT 
Rostral ventrolateral medulla (RVLM) plays a pivotal role in the tonic and phasic 
regulation of blood pressure. The present study was carried out to determine whether 
the excitatory amino acid (EAA) input to the RVLM contributed to elevated blood 
pressure and to assess the peripheral vascular reactivity in obesity-induced 
hypertension. Male Sprague-Dawley rats were fed with low-fat diet or moderately 
high-fat (MHF) diet for 16 weeks. Then, rats on MHF diet were segregated into 
obesity-prone (OP) and obesity-resistant (OR) rats based on the body weight 
distribution. OR rats were defined as rats with body weight similar or less than 
control rats (LF rats) while OP rats were defined as rats with greatest body weight. 
At week 16, rats were subjected to study the role of EAA on RVLM neurons or to 
study the peripheral vascular reactivity in obesity-induced hypertension. In the 
former study, L-glutamate (1 nmol) and kynurenic acid (KYN) at concentrations of 4 
nM, 40 nM and 4 µM were microinjected into RVLM and hexamethonium (20 
mg/kg) was administered intravenously. Brain stem was removed for histological 
verification and adiposity index was calculated. OP rats exhibited significantly larger 
weight gain, higher adiposity index and also elevated blood pressure. Pressor 
response to L-glutamate was greater in OP rats than in OR and LF rats, suggesting an 
increased responsiveness of the RVLM towards EAA and increased role of EAA 
input to RVLM vasomotor neurons. KYN injection at 40 nM reduced mean arterial 
xvii 
 
blood pressure (MAP) in OP rats only while at 4 nM no significant change in MAP 
was observed in any of the groups. KYN injection at 4 µM increased MAP in all 
groups. Results obtained suggest an imbalance of EAA input to the RVLM of obese 
rats, whereby, the balance has shifted towards the excitation leading to elevation of 
blood pressure. Secondly, increased inhibition of glutamate excitatory pathway by 
KYN may unmask other excitatory pathway that awaits further investigation. 
Hexamethonium produced a greater decrease in MAP in OP rats than OR and LF rats 
thus suggesting the presence of elevated sympathetic vasomotor tone in OP rats. For 
peripheral vascular reactivity study, different doses of intravenous noradrenaline 
(0.15-5 µg/kg), phenylephrine (1-32 µg/kg) and angiotensin II (3.75-120 ng/kg) 
produced greater dose-dependent pressor responses in MAP of pithed OP rats than in 
pithed OR and LF rats, reflecting an enhancement in peripheral vascular 
responsiveness to vasoactive agents that might have partly contributed to the elevated 
blood pressure in obesity-induced hypertensive rats. 
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CHAPTER ONE 
 
INTRODUCTION 
 
1.1 Obesity 
Obesity is a major health problem which is associated with poor quality of 
life and decreased life expectancy especially in the developed countries (Doll et al., 
2002; Davy and Orr, 2009), and worryingly in developing countries, the prevalence 
of obesity is increasing (Antic et al., 2003). In human, obesity is defined as having 
body mass index (BMI = body weight (kg) / height (m)
2 
) greater than 30 (Barton et 
al., 2003; Caballero, 2003; Stapleton et al., 2008).  
 
1.2 Characteristics of obesity 
Obesity develops when a person’s energy intake exceeds the expenditure, and 
body fat accumulates to an extent that can negatively affect health (Bruce-Keller et 
al., 2008; Gooren, 2008). This happens when there is lack of physical activity in 
lifestyle but excess calories intake which plays a dominant role in the development of 
obesity (Sowers, 2003; Eikelis and Esler, 2005). 
There is a body of evidence that shows obesity as a result of inherited gene 
that confers susceptibility, and also the environment that is becoming more 
obesogenic (Diaz, 2002; Sowers, 2003; Mercer and Archer, 2008). Cigarettes 
smoking, nutritional factors, such as dietary fat and psychological stress also 
contribute to the development of the obesity (Barton et al., 2003).  
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Adipose tissue particularly the visceral adipose tissues express predominantly 
β3-adrenergic receptors which play a pivotal role in the thermogenesis.  Studies in 
human have shown that β3-adrenergic receptor polymorphism affects the regulation 
of lipolysis and energy expenditure which eventually can act as a precursor to the 
pathology of obesity (Yasuda et al., 2006). 
In obesity-prone individuals, the thresholds for sensing hormonal and 
metabolic signals are genetically greater. These signals are important in inhibiting 
weight gain through their action on the network of metabolic sensing neurons that 
regulate the energy homeostasis. Thus, the raised threshold will diminish the effects 
of inhibitory signals which convey the message to the brain in the situation of excess 
of energy stores (Levin, 2005). 
Obesity has been associated with a number of diseases including 
hypertension, type II diabetes mellitus, atherosclerosis, focal-segmented 
glomerulosclerosis, albuminuria, dyslipidemia, insulin resistance and 
proinflammatory states (Diaz, 2002; Barton et al., 2003; Sowers, 2003; Grundy, 
2004). Obstructive sleep apnea also presents in obese hypertensive patients, and 
obesity is also a predisposing factor for the psychological problem such as anger, 
anxiety and depression (Naderali, 2008).  
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1.3 Obesity-related hypertension 
Obesity is intimately linked with hypertension in a way that an  increase in 
blood pressure is closely related to the magnitude of weight gain (Landsberg, 1986; 
1989; Rocchini et al., 1989; Hall et al., 1993). However, the exact mechanism 
linking both obesity and hypertension remains poorly understood.  Previous studies 
have reported that approximately 75% of cases of hypertension can be attributed to 
obesity. For an increase of 10 kg of body weight, there is a parallel increase of 3.0 
mmHg systolic and 2.3 mmHg of diastolic blood pressure. This minor increase in 
blood pressure can portend a 12% increase in coronary heart disease risk and a 24% 
increase in stroke risk (Mark et al., 1999; Aneja et al., 2004; Rahmouni et al., 2005a; 
Francischetti and Genelhu, 2007; Mittendorfer and Peterson, 2008).  
 
1.3.1 Characteristics of obesity-related hypertension 
Some alterations in hemodynamic parameters have been observed in obesity-
related hypertension. Cardiac output and blood flow are significantly increased with 
weight gain (Hall et al., 1993; 1999). Expanded blood volume and elevated 
ventricular filling pressure lead to the increase in stroke volume whereas; diminished 
cardiac vagal tone leads to an increase in resting heart rate. Increases in these two 
parameters thereby, contributing to the higher resting cardiac output. Blood flow 
tends to increase in obesity-induced hypertension in order to perfuse the excess 
adipose tissue mass as well as other regions, and the summation raises the cardiac 
output (Hall et al., 2000; Davy and Hall, 2004). 
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Obese hypertensive human has been shown to exhibit activated renin-
angiotensin system (RAS) and the sympathetic nervous system, elevated circulating 
leptin, and reduced growth hormone concentration (Montani et al., 2002). In 
addition, the levels of triglycerides and dyslipidemia are elevated that indicate low 
levels of HDL-cholesterol. Glomerulosclerosis in the kidney may occur as a result of 
hyperlipidemia which eventually leads to alteration in kidney function (Hall, 2003). 
Increased oxidative stress is also observed in obesity-related hypertension that 
predisposes to atherosclerosis (Dobrian et al., 2000). 
 
1.3.2 Sympathetic nervous system in obesity 
Sympathetic nervous system (SNS) plays a crucial role in the regulation of 
metabolic and cardiovascular homeostasis. Several lines of evidence have shown that 
there is an elevated sympathetic nervous activity in obesity (Esler, 2000; Montani et 
al., 2002; El Atat et al., 2003). This long-term overactivity of SNS causes a rise in 
blood pressure via peripheral vasoconstriction and increased in renal tubular sodium 
reabsorption (Kassab et al., 1995; Rahmouni et al., 2005a).  It is further supported by 
the observation that there is an increased muscle sympathetic nerve activity (MSNA) 
in obese normotensive subjects and lean hypertensive subjects. This study also 
demonstrates a greater increase in the MSNA of obese hypertensive subjects (Grassi 
et al., 2000; Alvarez et al., 2002).  Elevated level of SNS can be stimulated by 
increasing the caloric intake whereas fasting can reduce the sympathetic nervous 
activity (Antic et al., 2003; Davy and Hall, 2004; Rahmouni et al., 2005a). 
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1.3.3 Aetiology of obesity-related hypertension 
There are several potential mechanisms that contribute to the SNS activation 
in obese human. One of these is through RAS which seems to be activated in obesity 
(Boustany et al., 2004). In normotensive humans, infusion of angiotensin II increases 
the MSNA while inhibition of angiotensin converting enzyme decreases the activity 
(Davy and Orr, 2009). Treatment with angiotensin-converting enzyme inhibitor in 
obese dogs and obese hypertensive humans attenuates sodium retention and also 
decreases blood pressure thus supporting the significant role of angiotensin II in 
stimulating the renal sodium retention which then contributes to the elevation of 
blood pressure in obesity (Francischetti and Genelhu, 2007). Furthermore, it is well 
known that adipose tissues can release angiotensinogen (AGT) which is then 
converted to the active form of angiotensin II (Dandona et al., 2005; Rahmouni et 
al., 2005a; Mittendorfer and Peterson, 2008). Frederich and his colleagues had 
demonstrated that food intake plays a pivotal role in the expression of AGT in rat’s 
adipose tissue. They reported that level of AGT expression was significantly reduced 
when the rat was fasting while refeeding caused a marked increase in AGT 
expression of adipose tissue. This phenomenon is accompanied with parallel changes 
in blood pressure whereby, fasting leads to a fall and refeeding causes a rise in blood 
pressure, respectively. Thus, this finding suggests that changes in AGT expression in 
adipose tissue might contribute to the changes in systemic blood pressure associated 
with fasting and refeeding as the level of plasma AGT and hepatic AGT expression 
had not changed. It has been proposed that the presence of tumor necrosis factor 
(TNF) α might be the possible stimulator for the AGT gene expression, as there was 
an overexpression of this TNF-α mRNA and protein in adipose tissue of obese 
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subjects and animals. In addition, stimulation of AGT expression by TNF-α has been 
suggested in rat liver (Frederich et al., 1992; Engeli et al., 2000). 
It has also been reported that there is an upregulation of renin activity and 
aldosterone in obesity which lead to an increase in plasma volume and contraction of 
vascular smooth muscle, and in the end may result in increased blood pressure. 
Furthermore, previous study has also proven that weight loss is accompanied with a 
reduction in plasma renin activity and aldosterone which lead to a fall in blood 
pressure. Obesity may also be associated with an imbalance in the sympathovagal 
system. This was shown by heart rate variability studies and renal noradrenaline 
spillover studies. Obesity may increase the blood pressure as a result of increased 
sympathetic tone which leads to α1-adrenoceptor stimulation (El Atat et al., 2003; 
Mittendorfer and Peterson, 2008). 
Leptin, a 164-amino acid protein derived from adipocytes, promotes weight 
loss by reducing the food intake and increasing energy expenditure through an action 
on the arcuate nucleus of the hypothalamus.  Plasma leptin level is elevated in 
obesity due to resistance to its anorectic and weight-reducing effects (Haynes, 2005). 
However, elevated level of leptin in obesity does preserve the activation of the renal 
sympathetic nerve activity and exerts its effects through activation of the 
ventromedial and dorsomedial hypothalamus. This condition is referred as selective 
leptin resistance (Aizawa-Abe et al., 2000; Zhang and Reisin, 2000; Rahmouni et al., 
2005b; Francischetti and Genelhu, 2007). Administration of chronic leptin infusion 
in rats had significantly increased arterial blood pressure and heart rate as a result of 
increased sympathetic activity. This was confirmed by blockade of the adrenergic 
pathway which abolishes the effect (Monassier et al., 2006; Tentolouris et al., 2006). 
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Obese subjects are always accompanied with elevated insulin levels. Insulin 
acts on regions of the brain to promote reduction of food intake and increase of 
energy expenditure via sympathetically mediated thermogenesis. However, there is 
often a resistance to the actions of insulin in peripheral tissues. It has been reported 
that high levels of insulin in obese human and dogs do not have any effect on the salt 
excretion, sympathetic activity and blood pressure. Moreover, aspirin therapy to 
improve insulin resistance does not prevent the development of hypertension in high-
fat diet treated dogs, thus indicating that insulin resistance is not responsible for 
obesity-associated hypertension. Additionally, SNS activity and blood pressure are 
not elevated in patients with insulinoma, eventhough there is a presence of high 
fasting insulin plasma levels compared to lean subjects (Francischetti and Genelhu, 
2007). In dogs fed with high fat diet, clonidine pretreatment, a centrally active α2 –
agonist which inhibits central nervous sympathetic activation prevents the 
development of insulin resistance and hypertension (Rocchini et al., 1999). Further 
study by Rocchini et al. (2004) showed that peripheral α1– and β-blockade did not 
prevent the obesity-induced insulin resistance, indicating that hypertension and 
insulin resistance in obesity are not directly related. In contrast, high levels of insulin 
in rats do elevate blood pressure that may be mediated via complex interaction 
between insulin, RAS and thromboxane (TXA2) activity (El Atat et al., 2003; 
Rahmouni et al., 2005a).  
Obstructive sleep apnea (OSA) is another potential mechanism that can 
contribute to the activation of SNS in obesity-induced hypertension. OSA which is 
common in obesity is believed to evolve from episodic nocturnal sympathetic 
stimulation into ongoing, daytime sympathetic nervous activation. This is supported 
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by study on lean subjects with OSA which shows that there is some elevation of 
sympathetic tone. In addition, study on obese subjects with OSA shows a greater 
elevation of sympathetic tone (Esler et al., 2006).  
  Obesity also shows a characteristic of low-grade systemic inflammatory state 
as the adipocytes itself can release pro-inflammatory cytokines, interleukin-6 (IL-6) 
and TNF-α. Emerging data has shown the link between increased inflammation with 
a rise in blood pressure (Grundy, 2004; Mittendorfer and Peterson, 2008).  
Elevated free fatty acids (FFA) in obesity may cause a rise in blood pressure 
through two major mechanisms, namely endothelial dysfunction and sympathetic 
activation. High levels of FFA may inhibit the nitric oxide synthase activity thus 
blunts the vasodilatory response. FFA also has the capability to stimulate generation 
of oxygen radical from vascular endothelial and smooth muscle cells via activation 
of NADPH oxidase, thereby adding to the decreased nitric oxide bioavailability 
(Montani et al., 2002). It also can interact with the SNS by enhancing the vascular 
response to α-adrenergic agonists (Antic et al., 2003). Engeli and Sharma (2001) 
have also proposed that adipocyte-derived fatty acid can boost the release of a 
hepatic stimulator of aldosterone synthesis. 
Obesity has also been associated with several alterations in renal structure 
and functions. Adipose tissue which surrounds the kidney may increase the intrarenal 
pressure leading to impairment of pressure natriuresis, hence, contributing to the 
development of hypertension in obesity. Alterations in the histology of the renal 
medulla, such as increased interstitial cells and extracellular matrix mainly by 
glycosamino-glycan and hyaluran component, cause a rise in renal interstitial fluid 
pressure and tissue oedema. Consequently, the vasa recta blood flow is reduced 
                                                                                                                    
9 
 
while tubular reabsorption is increased due to compression of the thin Henle’s loops 
(Sharma, 2004; Francischetti and Genelhu, 2007). 
Natriuretic peptides act on its specific receptors to exert its effects on the 
plasma volume, renal sodium handling and blood pressure. These peptides can 
dampen the baroreceptor function and lower the activation threshold of vagal 
efferents which results in suppression of reflex tachycardia and vasoconstriction due 
to decreased extracellular volume. In obese subjects, there is an overexpression of 
the natriuretic peptide receptor type C (Npr-C) in adipose tissue which can 
negatively affect the systemic activity and actions of these peptides. As a result, these 
will lead to sodium retention and development of hypertension. Studies have shown 
that in obese subjects, urinary sodium excretion has been delayed whilst response of 
plasma ANP to saline load is blunted (Zhang and Reisin, 2000; El Atat et al., 2003; 
Aneja et al., 2004). 
Adiponectin, a 30 kDa protein which is also secreted by white fat, is known 
to enhance insulin sensitivity and also can stimulate oxidation of fatty acid in muscle. 
An in vitro study has shown that adiponectin can relax the aorta and mesenteric 
arteries. Adiponectin also can exert its effects on blood vessels whereby, its plasma 
levels have been correlated to vasodilator responses in human. Obesity has been 
associated with low plasma level of adiponectin while weight loss is associated with 
high plasma level of adiponectin (Sharma, 2004; Morris, 2008). 
Sympathetic activity can affect the baroreflex sensitivity. It has been shown 
that baroreflex sensitivity is reduced in obese man as compared to lean where men 
with higher visceral fat had lower baroreflex sensitivity than those with lower 
visceral fat (Grassi et al., 2000; Tentolouris et al., 2006). 
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Figure 1.1: General scheme of possible mechanisms involved in obesity-induced 
hypertension. A number of factors induced or potentiated by obesity lead to 
sympathetic activation, vasoconstriction and sodium retention, all promoting 
hypertension. FFA, free fatty acids; TNF-α, tumor necrosis factor; RAS, renin-
angiotensin system; NO, nitric oxide; Ang II, angiotensin II. Adapted from Montani 
et al. (2002). 
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1.4 Rat’s model of obesity-induced hypertension 
Animal models have been widely used as a tool to study the susceptibility to 
obesity in human. It includes genetically obese animals (Zucker rats), surgically 
induced obese rats (ventromedial hypothalamus-lesioned rat), spontaneously obese 
animals (rhesus monkeys) and diet-induced obese rat and mouse. Among these 
models, the dietary model developed by Levin in 1983 is the most relevant with 
regard to human obesity as it allows one to examine resistance and susceptibility to 
obesity. It also represents the genetic and environmental factors that may contribute 
to the development of obesity (Lauterio et al., 1994; 1998; Rahmouni et al., 2005b; 
Reuter, 2007) and also allows one to dissociate between the factors related to diet 
and obesity per se (Dobrian et al., 2000). However, that particular study by Levin 
(1983) did not measure any cardiovascular variables. 
In this model, rats on moderately high-fat diet (32% kcal as fat) for a certain 
period of time will be segregated into different groups based on the body weight 
distribution. One third of the rats whose body weight gain is greater, is considered as 
obesity-prone rats while one third lower is considered as obesity-resistant rats and 
the remainder is excluded from the study (Lauterio et al., 1998). A number of studies 
demonstrated the presence of elevated level of blood pressure, cholesterol and 
insulin, activation of RAS and increase in renal oxidative stress in obesity-prone rats 
(Carroll et al., 2006). Other than that, obesity-prone rats also exhibit characteristics 
that mimic the obese hypertensive patients, such as increased plasma noradrenaline 
response to intravenous glucose, increased plasma leptin concentration and decreased 
growth hormone secretion and synthesis (Dobrian et al., 2000).  
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1.5 Central baroreceptors pathway 
Baroreceptor reflex is important in maintaining the perfusion pressure in the 
face of disturbances of circulatory homeostasis through a number of neuronal and 
humoral regulatory adjustments. Alteration in the pressure load at the specialized 
pressure sensors which are located on the walls of aortic arc and carotid sinuses 
initiates these adjustments (Stauss, 2002).  
Baroreceptor afferent fibers that run from glossopharyngeal and vagal nerves 
provide tonic, excitatory input to neurons of the nucleus of the solitary tract (NTS) 
which is subjacent to the area postrema in the dorsomedial medulla during the resting 
blood pressure levels. Then, second-order NTS neurons that convey the baroreceptor 
signals project to caudal and intermediate part of the ventrolateral medulla (VLM) 
and excite the neurons. Neurons from the caudal part of the VLM (CVLM) project to 
rostral part of the VLM (RVLM) and inhibit the sympathoexcitatory neurons. It has 
been demonstrated that blockade of the inhibitory pathway to RVLM eliminate the 
baroreflex (Dampney et al., 2001; Alzamora et al., 2006; Kawabe et al., 2008). 
The neurons from the RVLM further project to sympathetic preganglionic 
neurons in the intermediolateral column of the spinal cord which is important in 
controlling the sympathetic vasomotor outflow (Bergamaschi et al., 1995; Gordon 
and Sved, 2002; Morrison, 2003; Iigaya et al., 2007). Baroreceptor sympathetic 
efferents regulate the heart, kidneys and also noradrenaline release (Guyenet, 2006). 
Meanwhile, alteration in the cardiac parasympathetic nerve activity which is evoked 
by baroreceptor is mediated by a direct excitatory projection from second order 
neurons in the NTS to the preganglionic parasympathetic neurons in the nucleus 
ambiguus (Sved et al., 2001).  
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Figure 1.2: Schematic sagittal view of the medulla oblongata depicting neural 
pathways involved in neurogenic hypertension. Premotor neurons of the RVLM 
provide excitatory drive to preganglionic neurons in the intermediolateral cell 
column (IML), which provide sympathetic output to target organs. RVLM neurons 
receive excitatory (▲) inputs from (1) forebrain structures, (2) commissural NTS, 
and (3) area postrema, and inhibitory (∆) inputs from the CVLM. The intermediate 
and commissural NTS represent the primary site of projection of afferent fibers 
arising from baro- and chemoreceptors. Increased excitatory inputs and/or decrease 
of inhibitory inputs result in enhancement of RVLM activity, thus increasing 
sympathetic output, a common feature of different forms of hypertension. Adapted 
from Colombari et al. (2001). 
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1.5.1 Central baroreceptor pathway in obesity-induced hypertension 
Baroreflex play a pivotal role in the acute and chronic regulation of body 
fluid volumes and arterial pressure but in chronic hypertension, baroreflex function is 
often impaired. There is an intriguing finding that shows the baroreflexes rapidly 
adapt and reset towards the existing level of the arterial pressure, but the magnitude 
and the time course of resetting remain unclear. Recently, a number of studies have 
suggested that baroreflexes resetting is incomplete in hypertension (Lohmeier et al., 
2002; 2003; 2007). 
Study using Fos-Li immunoreactivity in model of obesity-induced 
hypertension has shown that there is a chronic activation of the neurons subserving 
the baroreflexes. In this study, increased Fos staining in NTS and CVLM were 
observed thus indicating important roles of these regions in mediating baroreflex 
inhibition of sympathoexcitatory cells in RVLM. This finding is supported by the 
observation in animals with intact baroreflexes which shows similar response during 
acute elevations in arterial pressure, and also study in animals without baroreflexes 
which shows no increase in Fos staining in NTS and CVLM. Therefore, these 
findings indicate that activation of baroreflex is sustained during obesity 
hypertension and thus baroreflex-mediated sympathoinhibition is a long-term 
compensatory response in this model of hypertension. Eventhough activation of 
central baroreflex pathway is sustained in obesity hypertension, it has been shown 
that Fos-Li expression is significantly increased in the RVLM of obese dogs 
(Lohmeier et al., 2003), thereby supports other studies that showed increased 
sympathetic activity to the kidney and other vascular beds in obesity hypertension 
(Esler, 2000; Hall et al., 1999). Additionally, the presence of increased number of 
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Fos-Li cells in obese dogs may reflect the dominant action of excitatory inputs over 
chronic inhibitory effects of the baroreflex to the RVLM (Lohmeier et al., 2003). 
Another study in obesity-induced hypertensive rats with intact baroreflex 
showed that reflex bradycardia was reduced during pressor responses to 
phenylephrine but no difference was observed in reflex tachycardia during depressor 
responses to sodium nitroprusside in both obese hypertensive rats and control. 
Similar inhibition of reflex tachycardia was seen in both groups after either 
cholinergic or β-adrenergic blockade by methylatropine or propranolol. Meanwhile, 
reflex bradycardia was reduced more in obese-hypertensive rats than in control rats 
but equally reduced after β-adrenergic and cholinergic blockade respectively. Hence, 
it is postulated that selective impairment of reflex bradycardia might be due to 
deficient of parasympathetic activity since blockade of β-adrenergic would leave 
only residual reflex responses by parasympathetic activity (Bunag et al., 1990). 
 
1.5.2 Rostral ventrolateral medulla 
Rostral ventrolateral medulla (RVLM) plays a pivotal role in the tonic and 
phasic regulation of cardiovascular function (Lipski et al., 1996; Araujo et al., 1999; 
Campos and McAllen, 1999; Ito et al., 2001; 2002; Mayorov and Head, 2002; 
Granata and Cohen, 2004; Oshima et al., 2006; Menezes and Fontes, 2007). RVLM 
bulbospinal neurons that project directly to sympathetic preganglionic neurons in the 
spinal cord, thus called ‘presympathetic’ neurons are a major source of basal tonic 
sympathetic vasomotor activity (Yang and Coote, 1998; Tagawa and Dampney, 
1999; Potts et al., 2000; Hu et al., 2002; Horiuchi and Dampney, 2002; Dampney et 
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al., 2003;  Oshima et al., 2006;). These tonic excitations of sympathetic vasomotor 
outflow are important in maintaining normal arterial blood pressure (Brooks et al., 
2004; Horiuchi et al., 2004). Therefore, any neuronal inhibition of RVLM will 
markedly result in decrease in arterial pressure. These RVLM neurons receive both 
excitatory and inhibitory synaptic inputs resulted from stimulation of peripheral 
receptors and also higher center in the brain (Horiuchi et al., 2004). 
Numerous studies have shown that RVLM neurons are tonically active but 
the tonic excitatory drive to the neurons remains unclear (Horiuchi et al., 2004; 
Stocker et al., 2007). However, it is believed that the tonic excitatory input arise 
from one or combination of afferents to the RVLM. Studies on neuroanatomical has 
documented some brain regions which project to the vasomotor area of the RVLM. 
In rats, some regions have been identified including CVLM, NTS, area postrema, 
raphe nuclei, A5 neurons, hypothalamic paraventricular neurons (PVN), central 
amygdaloid nucleus, periaqueductal gray (PAG), parabrachial nucleus and lateral 
hypothalamic area (LHA). Inhibition of these brain regions individually did not lead 
to marked decrease in arterial pressure indicating that there might be two or more 
regions that drive tonic excitatory input to the RVLM. Thus, marked decrease in 
arterial pressure would only be observed after inhibition of correct combination of 
these regions (Sved et al., 2001; Pilowsky and Goodchild, 2002; Dampney et al., 
2003). 
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1.5.2.1 Neurotransmitters and neuromodulators in RVLM 
RVLM neurons consist of heterogenous cell population whereby, different 
genes, different complement of receptors, transmitters, enzymes and other proteins 
are found in different subpopulations of bulbospinal RVLM neurons. These includes 
glutamate, catecholamines, preproenkephalin/enkephalin, substance P, neuropeptide 
Y, cocaine- and amphetamine-regulated transcript, preprogalanin, calbindin, GABAA 
and GABAB receptors, P2X receptors, alpha2A-adrenergic receptors, angiotensin1A 
receptors, and mu opioid receptors. Among these, the key for neurochemical within 
RVLM are those involved glutamate and GABA transmission (Pilowsky and 
Goodchild, 2002). 
Glutamate is an excitatory amino acid (EAA) which acts as a principle 
neurotransmitter in the central nervous system (Goren et al., 2000; Gonzalez and 
Robinson, 2004; Maragakis and Rothstein, 2004; Shigeri et al., 2004; Bridges and 
Esslinger, 2005). Glutamate is released into the synaptic cleft and bind to glutamate 
receptors resulted in propagation of action potential. Apart from glutamate receptors, 
glutamate transporters also play a role in modulation of the synaptic activity by 
removing the glutamate from the synaptic cleft.  Studies have proven the importance 
of glutamate in normal central nervous system synaptic function. However, excess 
accumulation of glutamate in the synaptic cleft can lead to neurotoxicity. Defects in 
the function of glutamate transporters lead to a rise in extracellular glutamate which 
then results in the development of neurologic disease. Glutamate transporters 
dysfunction might be a result of alteration in transcription or splicing, increased 
turnover of the transporters, altered trafficking of glutamate transporter, abnormal 
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protein phosphorylation and reduced transport capacity (Maragakis and Rothstein, 
2004; Boeck et al., 2005). 
Glutamate can act on two main classes of receptors which are ionotropic (ion-
channel linked) and metabotropic receptors (G-protein linked) (Tsuchihashi et al., 
1994). The latter receptors couple to the intracellular second messenger cascades via 
G-proteins (Tsuchihashi et al., 2000; Herlenius and Lagercrantz, 2004; 
Vandenberghe and Bredt, 2004; Galik et al., 2008). Ionotropic glutamate receptors 
can be subdivided into two types which are N-methyl-D-aspartate (NMDA) and non-
NMDA receptors based on their sensitivity to agonists and differing molecular 
structures. Non-NMDA receptors can be further classified into kainate and AMPA 
receptors. Each class of glutamate receptors (GluRs) has their own subunits whereby, 
NMDA receptors consist of NR1and NR2A-NR2D. Meanwhile, GluR1-GluR4 
represents the AMPA-sensitive family and GluR5-GluR7, KA1 and KA2 belong to 
kainate family (Smart, 1997; Pamidimukkala et al., 2002). 
Gamma-aminobutyric acid (GABA) is a dominant inhibitory neurotransmitter 
in the central nervous system of the mature animal. GABA can acts on two types of 
receptors namely, GABAA and GABAB receptor. GABAA receptor is a 
transmembrane protein wherein, other substances like barbiturate and 
benzodiazepines can bind to specific sites and thus modulating the opening 
properties of the chloride channel. These receptors have different pharmacological 
and electrophysiological properties depending on their subunit composition. GABAB 
receptor (G protein-coupled) which is present in lower level in the central nervous 
system, performs its function late in the development of central nervous system 
(Herlenius and Lagercrantz, 2004).  
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Nerve cells contain high concentration of chloride during the early 
development of the central nervous system. Therefore, opening of the chloride 
channel by GABA leads to depolarization (i.e., excitation) to occur. By contrast, the 
decrease in chloride concentration during maturation led to an opposite effect of 
GABA whereby, chloride ions are pumped out and cell hyperpolarization occurs. 
Hence, GABA switches its role from excitatory to inhibitory neurotransmitter in the 
mature animal (Herlenius and Lagercrantz, 2004).  
Kynurenic acid (KYN), an endogenous tryptophan metabolite is present in 
the mammalian central nervous system. Increase level of KYN in the brain is related 
with sedation, analgesia and reduction of post-ischaemic or post-inflammatory 
damage. KYN has the capability to reduce the neurotoxic effects of glutamate by 
acting on the glutamate ionotropic receptors (Stone and Addae, 2002; Prescott et al., 
2006; Moroni et al., 2007). 
Nitric oxide (NO) is present with varying amounts in most of the brain 
regions. NO is synthesized from the amino acid L-arginine by nitric oxide synthase 
(NOS) (Raevskii, 1997).  NO plays a vital role in many functions of the nervous 
system including memory, learning, vision and cardiovascular regulation.  NO can 
act centrally, decreasing the sympathetic nerve activity and blood pressure 
(Dominiczak and Bohr, 1995; Zhang and Patel., 1998; Patel et al., 2001). Recent 
study reported that high levels of NO can reduce glutamate presynaptic release via 
inhibition of presynaptic N-type Ca
2+ 
-channel activity thereby, depressing the 
RVLM neurons (Tai et al., 2005).  
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1.5.2.2 Tonic glutamatergic input to RVLM presympathetic neurons 
Numerous studies have demonstrated that RVLM presympathetic neurons 
receive excitatory glutamatergic synaptic input which originate from both medullary 
and supramedullary regions (Dampney et al., 2003). There are some possible sources 
of this glutamatergic synaptic input such as input from pontine reticular formation, 
lateral tegmental field and also from the PVN of the hypothalamus. Blockade of 
ionotropic glutamate receptors in the RVLM of cat and rabbit caused a profound 
reduction in blood pressure indicating that glutamatergic synaptic input is the main 
source of tonic excitatory drive to RVLM (Barman et al., 2000; Hourichi and 
Dampney, 2002; Sved et al., 2002).  
 
1.5.2.3 Tonic GABAergic input to RVLM presympathetic neurons 
Studies have reported that there is a presence of tonic GABAergic input to the 
RVLM neurons. This GABAergic input to RVLM is mediated partly via neurons of 
the caudal aspect of the VLM (CVLM) (Sved and Gordon, 1994). Furthermore, tonic 
GABAergic input to the RVLM presympathetic neurons are also partly engaged in 
baroreceptor-independent regulatory mechanism. Inhibitory action of GABA on 
RVLM neurons is mediated preferentially through activation of GABAA receptor. 
Blockade of this GABAA receptor in the sympathoexcitatory regions of the RVLM 
eliminates the action of inhibitory vasomotor neurons from the caudal part thus 
results in large increase in sympathetic nerve activity and blood pressure (Moreira et 
al., 2005; Menezes and Fontes, 2007). 
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1.5.2.4 Intrinsic pacemaker of RVLM 
  Apart from synaptic input which is driven by neurons located elsewhere in 
the brain, it has been speculated that tonic activity of RVLM neurons can also be 
generated by intrinsic pacemaker activity which is capable of generating action 
potentials (autoactivity) (Lewis and Coote, 1993; Dampney et al., 2003; Coote, 
2006).  This theory arises due to failure of blockade of glutamate receptors to cause 
significant reduction of tonic discharge of RVLM neurons. In addition, removal of 
synaptic input by blockade of excitatory or inhibitory EAA receptors or during 
perfusion of low-Ca
2+ 
high-Mg
2+ 
solution did not affect the regular and irregular 
discharge of RVLM neurons in brain slice. This theory is further supported by the 
fact that action potential in RVLM neurons was not initiated by EPSPs, the regular 
discharge was reset by an experimentally given stimulus and the discharge was 
eliminated by membrane hyperpolarization with no residual EPSPs. Besides, other 
membrane properties which were exhibited by the cells could also contribute to the 
intrinsic oscillating depolarization (Lewis and Coote, 1993; Coote, 2006). 
Nevertheless, such intrinsic activity of ‘pacemaker’ neurons was only 
recorded in vitro in isolated medulla and spinal cord but not in vivo. Intracellular 
recordings of identified RVLM presympathetic neurons in vivo showed irregular 
low-frequency action potentials which triggered by EPSPs (Lipski et al., 1996; 
Coote, 2006) and in accordance with the pattern of discharge from synaptic drive 
observed in sympathetic preganglionic neurons (Coote, 2006). This theory also failed 
to explain the basic rhythmic oscillations of activity in RVLM presympathetic 
neurons which are related with similar activity in postganglionic sympathetic nerves. 
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It also cannot explain the non-uniformity of sympathetic activity in different 
vasomotor nerves.  
Therefore, synaptic drive is the most probably source of tonic activity in 
RVLM neurons in unchallenged adult animal. However, some considerable condition 
should be taken into account. For instance, specific slow synaptic input due to its 
removal could induce activation of selective inward currents which has been shown 
to trigger beating activity in RVLM neurons in vitro as a response to challenging 
environmental stimuli (Coote, 2006). 
 
1.5.2.5 RVLM in obesity-induced hypertension 
Sved and his colleagues had proposed that sympathetic vasomotor outflow 
from RVLM neurons is maintained by balance of excitatory and inhibitory input 
(Sved et al., 2001). In normotensive rats, administration of KYN, an EAA antagonist 
into RVLM did not produce any effect on the arterial blood pressure (Ito et al., 
2002). This indicated that under resting conditions, direct excitatory and indirect 
inhibitory influences of EAA are in perfect balance whereby, activation of the 
CVLM inhibitory mechanisms counterbalances the excitatory drive to the RVLM 
neurons. Blockade of the EAA receptors in the RVLM simultaneously removed both 
of the influence of tonic excitation and inhibition which led to no net change in 
sympathetic vasomotor activity and arterial blood pressure (Sved et al., 2002; 
Horiuchi et al., 2004). However, blockade of EAA receptors in RVLM in 
combination with CVLM inhibition using muscimol (GABA agonist) did cause a 
profound fall in arterial blood pressure indicating that RVLM does receive important 
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tonic excitatory drive. In contrast, injection of muscimol into CVLM alone results in 
increase of both sympathetic activity and arterial blood pressure due to release of 
excitatory mechanisms to the RVLM (Moreira et al., 2005). 
However, in models of experimental hypertension, the excitatory and 
inhibitory balance is altered (Ito et al., 2002). In Dahl-sensitive model, the balance of 
excitatory amino acid input was disrupted, whereby; the balance is shifted towards 
excitation in Dahl-sensitive rats as compared with Dahl-resistant rats. A significant 
drop in mean arterial pressure was recorded after microinjection of KYN into the 
RVLM
 
(Ito et al., 2001). In addition, disruption in the balance of excitatory and 
inhibitory input was also observed in spontaneously hypertensive rat (SHR) (Ito et 
al., 2000). 
In addition, recent study has proven that the RVLM neurons do contribute to 
obesity-induced hypertension in rats. However, the finding only indicates that the 
tonic activity of RVLM neurons is necessary for the elevated blood pressure in 
obesity-hypertension rats but it does not demonstrate that the tonic activity of RVLM 
neurons is elevated (Stocker et al., 2007).  
Thus, this present study aims to investigate the neural pathways that underlie 
the activation of RVLM neurons by determining whether EAA input particularly L-
glutamate within the RVLM neurons do contribute to elevated blood pressure in 
obesity. For this purpose, we investigate further if the microinjections of EAA-
receptor antagonist into RVLM vicinity result in a reduction of arterial pressure in 
obesity-induced hypertensive rats.  
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1.6 Study on peripheral vascular reactivity 
Previous study has demonstrated that elevated blood pressure in diet-induced 
obesity rats is associated with an enhanced vascular contractility (Boustany-Kari et 
al., 2007). However, such finding was observed in in vitro preparation of the 
mesenteric arteries of the rats, thus not presenting the whole animal system. 
Numerous studies has been carried out using pithed rats (Fozard and Leach, 1968; 
Barret, 1971; Dong et al., 1995; Gavin and Docherty, 1996; Zhou and Vargas, 1996; 
Dendorfer et al., 1999; Elayan et al., 2002; 2008; Cobos-Puc et al., 2007) as pithing 
eliminates the central reflex responses to the pressor effects upon peripheral 
stimulation. Therefore, availability of this pithing technique enables us to assess in 
vivo peripheral vascular reactivity in the rat’s model of obesity-induced hypertension. 
 
1.6.1 Endothelial dysfunction in obesity-induced hypertension 
Obesity is closely related with increased risk for hypertension whereby, 
inflammation, vascular remodeling and changes in vascular reactivity are the leading 
role in the pathogenesis of this disease (Mundy et al., 2007).  Abnormalities of 
arterial function and structures have been observed in obese human and in certain 
animal models of obesity including the changes in release of vasoactive substances 
from the endothelial cells and also elasticity of the arterial wall. Naderali and his 
colleagues have reported that endothelial dysfunction can occur as a result of acute 
consumption of a palatable diet long before development of any significant obesity.  
Short term withdrawal of this palatable diet incompletely corrected the endothelial 
dysfunction. However, endothelial dysfunction can be corrected completely by 
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chronic removal of palatable diet which indicates that diet per se plays an important 
role in the development of vascular abnormalities in animal models of obesity 
(Naderali et al., 2004). 
Endothelial dysfunction in obesity is due to alteration in the synthesis/release 
of prostanoids and nitric oxide. These substances play a vital role in the regulation of 
the vascular tone (Mascher et al., 2006). Prostacyclin (PGI2) is mainly generated in 
endothelial cells from arachidonic acid. PGI2 can cause vasodilation through 
activation of protein kinase A which reduce the myosin light chain kinase activity 
and also can inhibit platelet aggregation (Khazaei et al., 2008).  
Experimental studies in animal model of obesity has shown the presence of 
oxidative stress which can lead to the endothelial dysfunction. Oxidative stress can 
block the nitric oxide synthase and also inactivate the action of nitric oxide, thus 
impairing the NO-mediated vasorelaxation. It can also cause an increase in 
generation of endothelin-1 and increase effects of the superoxide anion and hydrogen 
peroxide on vascular smooth muscle cells (Wolk et al., 2003).  
 Insulin acts as a vasodilator that can affect the peripheral resistance in normal 
vasculature. Insulin acts by inhibiting the voltage-gated Ca
2+ 
influx and stimulating 
the glucose transport and glucose phosphorylation, thus leading to activation of Ca
2+
 
ATPase transcription and also increase in cellular Ca
2+ 
efflux.  As a result, there is 
decrease in vascular resistance due to net decrease of intracellular Ca
2+
. However, the 
presence of insulin resistance in obesity blunt these effects, thereby increases the 
vascular resistance (Zhang and Reisin, 2000). 
 
